Aptevo Therapeutics Inc.

APVO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.84

$0 (0.00%)

At close: Sep 21, 2026, 3:59 PM ET

$1.79

-$0.05 (-2.45%)

Pre-market: Sep 22, 2026, 7:19 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-25.97M	-24.13M	-17.41M	8.03M	-28.46M	-17.75M
Depreciation & Amortization	240K	352K	567K	901K	1.14M	1.31M
Stock-Based Compensation	96K	1.07M	2.19M	1.8M	1.64M	1.26M
Other Working Capital	-893K	-1.16M	-107K	2.54M	-740K	665K
Other Non-Cash Items	1.09M	1.1M	10K	-33.9M	6.64M	-12.43M
Deferred Income Tax	n/a	n/a	n/a	n/a	4K	n/a
Change in Working Capital	-1.05M	-2.18M	2.91M	2.14M	-2.66M	-1.7M
Operating Cash Flow	-25.59M	-23.79M	-11.73M	-21.02M	-21.68M	-29.32M
Capital Expenditures	n/a	n/a	n/a	-29K	-713K	-88K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	28.12M
Investing Cash Flow	n/a	n/a	n/a	-29K	-713K	28.03M
Debt Repayment	n/a	n/a	-3.47M	-12.27M	-10.55M	2.63M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-11K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-4K	3.04M	2.72M	26.48M	21.26M
Financial Cash Flow	38.5M	15.6M	6M	-2.62M	26.16M	23.87M
Net Cash Flow	12.91M	-8.19M	-5.73M	-23.67M	3.77M	22.59M
Free Cash Flow	-25.59M	-23.79M	-11.73M	-21.05M	-22.39M	-29.41M
Adj. Free Cash Flow	-25.69M	-24.85M	-13.92M	-22.85M	-24.04M	-30.66M
Maintenance CapEx	n/a	n/a	n/a	-29K	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-713K	-88K
Owner Earnings	-25.59M	-23.79M	-11.73M	-21.05M	-21.68M	-29.32M